StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
INDV

Indivior Pharmaceuticals, Inc.

INDV Nasdaq Pharmaceutical Preparations EDGAR ↗
$37.37
-2.64 -6.60%

Key statistics

from XBRL data in SEC filings
Market cap
$4.41B
Revenue (TTM)
$1.33B
Net income (TTM)
$356M
EPS (TTM)
$2.79
P/E ratio
13.4
Dividend yield
Free cash flow
-$93.0M
Cash
$222M
Total assets
$1.23B
Gross margin
82.2%
52-week range
$21.16 – $42.81

Recent SEC filings

40 most recent
Annual, quarterly & current reports
10-Q Quarter ended 2026-06-30 Aug 3, 2026 8-K Regulation FD disclosure Aug 3, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Aug 3, 2026 8-K Entered a material agreement; Regulation FD disclosure Aug 3, 2026 8-K Director or officer change; Shareholder vote results May 15, 2026 8-K Regulation FD disclosure; Other events May 4, 2026 10-Q Quarter ended 2026-03-31 Apr 30, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Apr 30, 2026 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Unregistered sale of equity Mar 17, 2026 8-K Other events Mar 13, 2026 8-K Other events Mar 12, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Feb 26, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Modified rights of security holders; Change in control; Director or officer change; Amended charter or bylaws; Item 5.05; Regulation FD disclosure; Other events Jan 26, 2026 8-K Regulation FD disclosure Jan 8, 2026 8-K Regulation FD disclosure Dec 22, 2025 8-K Director or officer change Dec 18, 2025 8-K Amended charter or bylaws; Shareholder vote results Dec 15, 2025 8-K Terminated a material agreement; Regulation FD disclosure Nov 20, 2025 8-K Regulation FD disclosure Nov 14, 2025 8-K/A Exit or disposal costs Oct 30, 2025 10-Q Quarter ended 2025-09-30 Oct 30, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Oct 30, 2025 8-K Regulation FD disclosure Oct 1, 2025 8-K Exit or disposal costs Aug 26, 2025 8-K Director or officer change Aug 22, 2025 8-K/A Director or officer change Aug 4, 2025 10-Q Quarter ended 2025-06-30 Jul 31, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jul 31, 2025 8-K Regulation FD disclosure Jun 30, 2025 8-K Director or officer change; Other events Jun 24, 2025 8-K Regulation FD disclosure Jun 2, 2025 8-K Other events Jun 2, 2025 8-K/A Shareholder vote results May 12, 2025 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results; Regulation FD disclosure May 8, 2025 10-Q Quarter ended 2025-03-31 May 1, 2025 8-K Results of operations (earnings release) Apr 24, 2025 8-K Regulation FD disclosure Mar 27, 2025 8-K Entered a material agreement; Director or officer change Mar 4, 2025 10-K Fiscal year ended 2024-12-31 Mar 3, 2025